Publication Information

{'id': 'https://openalex.org/W4394724610', 'doi': 'https://doi.org/10.1002/1878-0261.13641', 'title': '<scp>TAS</scp>3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer', 'display_name': '<scp>TAS</scp>3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer', 'publication_year': 2024, 'publication_date': '2024-04-10', 'ids': {'openalex': 'https://openalex.org/W4394724610', 'doi': 'https://doi.org/10.1002/1878-0261.13641', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/38600681'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/1878-0261.13641', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1878-0261.13641', 'source': {'id': 'https://openalex.org/S80282989', 'display_name': 'Molecular Oncology', 'issn_l': '1574-7891', 'issn': ['1574-7891', '1878-0261'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1878-0261.13641', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5101506020', 'display_name': 'Shohei Yoshida', 'orcid': 'https://orcid.org/0000-0002-2294-2387'}, 'institutions': [{'id': 'https://openalex.org/I4210120269', 'display_name': 'Taiho Pharmaceutical (Japan)', 'ror': 'https://ror.org/02v50dx14', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210120269']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Shohei Yoshida', 'raw_affiliation_strings': ['Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan'], 'affiliations': [{'raw_affiliation_string': 'Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan', 'institution_ids': ['https://openalex.org/I4210120269']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002498835', 'display_name': 'Daisuke Kajiwara', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210120269', 'display_name': 'Taiho Pharmaceutical (Japan)', 'ror': 'https://ror.org/02v50dx14', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210120269']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Daisuke Kajiwara', 'raw_affiliation_strings': ['Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan'], 'affiliations': [{'raw_affiliation_string': 'Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan', 'institution_ids': ['https://openalex.org/I4210120269']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039528741', 'display_name': 'Masanao Seki', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210120269', 'display_name': 'Taiho Pharmaceutical (Japan)', 'ror': 'https://ror.org/02v50dx14', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210120269']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Masanao Seki', 'raw_affiliation_strings': ['Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan'], 'affiliations': [{'raw_affiliation_string': 'Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan', 'institution_ids': ['https://openalex.org/I4210120269']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5020680623', 'display_name': 'Manabu Tayama', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210120269', 'display_name': 'Taiho Pharmaceutical (Japan)', 'ror': 'https://ror.org/02v50dx14', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210120269']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Manabu Tayama', 'raw_affiliation_strings': ['Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan'], 'affiliations': [{'raw_affiliation_string': 'Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan', 'institution_ids': ['https://openalex.org/I4210120269']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101794234', 'display_name': 'Yuki Tanaka', 'orcid': 'https://orcid.org/0000-0001-9822-9804'}, 'institutions': [{'id': 'https://openalex.org/I4210120269', 'display_name': 'Taiho Pharmaceutical (Japan)', 'ror': 'https://ror.org/02v50dx14', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210120269']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yuki Tanaka', 'raw_affiliation_strings': ['Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan'], 'affiliations': [{'raw_affiliation_string': 'Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan', 'institution_ids': ['https://openalex.org/I4210120269']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110382420', 'display_name': 'Hiroya Mizutani', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210120269', 'display_name': 'Taiho Pharmaceutical (Japan)', 'ror': 'https://ror.org/02v50dx14', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210120269']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hiroya Mizutani', 'raw_affiliation_strings': ['Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan'], 'affiliations': [{'raw_affiliation_string': 'Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan', 'institution_ids': ['https://openalex.org/I4210120269']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109602294', 'display_name': 'Ryoto Fujita', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210120269', 'display_name': 'Taiho Pharmaceutical (Japan)', 'ror': 'https://ror.org/02v50dx14', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210120269']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Ryoto Fujita', 'raw_affiliation_strings': ['Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan'], 'affiliations': [{'raw_affiliation_string': 'Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan', 'institution_ids': ['https://openalex.org/I4210120269']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5086224338', 'display_name': 'Keisuke Yamamura', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210120269', 'display_name': 'Taiho Pharmaceutical (Japan)', 'ror': 'https://ror.org/02v50dx14', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210120269']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Keisuke Yamamura', 'raw_affiliation_strings': ['Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan'], 'affiliations': [{'raw_affiliation_string': 'Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan', 'institution_ids': ['https://openalex.org/I4210120269']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5008938286', 'display_name': 'Shigeo Okajima', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210120269', 'display_name': 'Taiho Pharmaceutical (Japan)', 'ror': 'https://ror.org/02v50dx14', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210120269']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Shigeo Okajima', 'raw_affiliation_strings': ['Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan'], 'affiliations': [{'raw_affiliation_string': 'Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan', 'institution_ids': ['https://openalex.org/I4210120269']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5073040939', 'display_name': 'Masanori Asai', 'orcid': 'https://orcid.org/0000-0001-9931-3549'}, 'institutions': [{'id': 'https://openalex.org/I4210120269', 'display_name': 'Taiho Pharmaceutical (Japan)', 'ror': 'https://ror.org/02v50dx14', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210120269']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Masanori Asai', 'raw_affiliation_strings': ['Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan'], 'affiliations': [{'raw_affiliation_string': 'Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan', 'institution_ids': ['https://openalex.org/I4210120269']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5083062503', 'display_name': 'Kazuhisa Minamiguchi', 'orcid': 'https://orcid.org/0009-0007-6801-6614'}, 'institutions': [{'id': 'https://openalex.org/I4210120269', 'display_name': 'Taiho Pharmaceutical (Japan)', 'ror': 'https://ror.org/02v50dx14', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210120269']}], 'countries': ['JP'], 'is_corresponding': True, 'raw_author_name': 'Kazuhisa Minamiguchi', 'raw_affiliation_strings': ['Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan'], 'affiliations': [{'raw_affiliation_string': 'Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan', 'institution_ids': ['https://openalex.org/I4210120269']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5083062503'], 'corresponding_institution_ids': ['https://openalex.org/I4210120269'], 'apc_list': {'value': 3600, 'currency': 'USD', 'value_usd': 3600, 'provenance': 'doaj'}, 'apc_paid': {'value': 3600, 'currency': 'USD', 'value_usd': 3600, 'provenance': 'doaj'}, 'fwci': 10.372, 'has_fulltext': False, 'cited_by_count': 4, 'citation_normalized_percentile': {'value': 0.999971, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '18', 'issue': '8', 'first_page': '1980', 'last_page': '2000'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11041', 'display_name': 'Ubiquitin and proteasome pathways', 'score': 0.9886, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11395', 'display_name': 'Radiopharmaceutical Chemistry and Applications', 'score': 0.9789, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.9917095}], 'concepts': [{'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.9917095}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.8976645}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.84218395}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.63098276}, {'id': 'https://openalex.org/C2777911890', 'wikidata': 'https://www.wikidata.org/wiki/Q62614', 'display_name': 'Androgen', 'level': 3, 'score': 0.4569048}, {'id': 'https://openalex.org/C62478195', 'wikidata': 'https://www.wikidata.org/wiki/Q828130', 'display_name': 'Signal transduction', 'level': 2, 'score': 0.45289508}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.41896874}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.4059307}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.38689557}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.38115346}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.31698012}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.29716212}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.2845046}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.15724093}, {'id': 'https://openalex.org/C71315377', 'wikidata': 'https://www.wikidata.org/wiki/Q11364', 'display_name': 'Hormone', 'level': 2, 'score': 0.0995796}], 'mesh': [{'descriptor_ui': 'D059002', 'descriptor_name': 'Androgen Receptor Antagonists', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001549', 'descriptor_name': 'Benzamides', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D045744', 'descriptor_name': 'Cell Line, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D049109', 'descriptor_name': 'Cell Proliferation', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008819', 'descriptor_name': 'Mice, Nude', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D010669', 'descriptor_name': 'Phenylthiohydantoin', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D011471', 'descriptor_name': 'Prostatic Neoplasms', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D064129', 'descriptor_name': 'Prostatic Neoplasms, Castration-Resistant', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D011944', 'descriptor_name': 'Receptors, Androgen', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D015398', 'descriptor_name': 'Signal Transduction', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D023041', 'descriptor_name': 'Xenograft Model Antitumor Assays', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 3, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/1878-0261.13641', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1878-0261.13641', 'source': {'id': 'https://openalex.org/S80282989', 'display_name': 'Molecular Oncology', 'issn_l': '1574-7891', 'issn': ['1574-7891', '1878-0261'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11306513', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/38600681', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/1878-0261.13641', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1878-0261.13641', 'source': {'id': 'https://openalex.org/S80282989', 'display_name': 'Molecular Oncology', 'issn_l': '1574-7891', 'issn': ['1574-7891', '1878-0261'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.82}], 'grants': [{'funder': 'https://openalex.org/F4320311653', 'funder_display_name': 'Taiho Pharmaceutical', 'award_id': None}], 'datasets': [], 'versions': [], 'referenced_works_count': 54, 'referenced_works': ['https://openalex.org/W1848444843', 'https://openalex.org/W1992166168', 'https://openalex.org/W2001201137', 'https://openalex.org/W2017919614', 'https://openalex.org/W2032131631', 'https://openalex.org/W2037347495', 'https://openalex.org/W2037700362', 'https://openalex.org/W2041034966', 'https://openalex.org/W2043179716', 'https://openalex.org/W2051025382', 'https://openalex.org/W2055655957', 'https://openalex.org/W2056731938', 'https://openalex.org/W2067312336', 'https://openalex.org/W2084637523', 'https://openalex.org/W2097226696', 'https://openalex.org/W2109877347', 'https://openalex.org/W2110534364', 'https://openalex.org/W2113302239', 'https://openalex.org/W2119504728', 'https://openalex.org/W2121098984', 'https://openalex.org/W2121846636', 'https://openalex.org/W2148643283', 'https://openalex.org/W2156923287', 'https://openalex.org/W2157980218', 'https://openalex.org/W2160463964', 'https://openalex.org/W2166912270', 'https://openalex.org/W2167634604', 'https://openalex.org/W2212015457', 'https://openalex.org/W2261870911', 'https://openalex.org/W2271989793', 'https://openalex.org/W2340799873', 'https://openalex.org/W2345132842', 'https://openalex.org/W2399469784', 'https://openalex.org/W2401991052', 'https://openalex.org/W2403998898', 'https://openalex.org/W2486721152', 'https://openalex.org/W2504254225', 'https://openalex.org/W2611637096', 'https://openalex.org/W2753147836', 'https://openalex.org/W2760948449', 'https://openalex.org/W2777172225', 'https://openalex.org/W2883836317', 'https://openalex.org/W2897146989', 'https://openalex.org/W2904574097', 'https://openalex.org/W2908533946', 'https://openalex.org/W2921495719', 'https://openalex.org/W2944090322', 'https://openalex.org/W2977827677', 'https://openalex.org/W3092518991', 'https://openalex.org/W3149254134', 'https://openalex.org/W3165318783', 'https://openalex.org/W3170708393', 'https://openalex.org/W3211281229', 'https://openalex.org/W4322744661'], 'related_works': ['https://openalex.org/W3122236002', 'https://openalex.org/W3024577600', 'https://openalex.org/W3023935924', 'https://openalex.org/W2773216890', 'https://openalex.org/W2681186693', 'https://openalex.org/W2593283143', 'https://openalex.org/W2479406918', 'https://openalex.org/W2180958531', 'https://openalex.org/W1993338898', 'https://openalex.org/W1848444843'], 'abstract_inverted_index': {'Second-generation': [0], 'androgen': [1], 'receptor': [2], '(AR)': [3], 'signaling': [4], 'inhibitors': [5], '(ARSIs),': [6], 'such': [7], 'as': [8], 'abiraterone': [9], 'and': [10, 41, 58, 63, 72, 85, 111, 128, 135, 137], 'enzalutamide,': [11, 105, 134], 'prolong': [12], 'the': [13, 67, 118, 151], 'life': [14], 'of': [15, 70, 121, 153, 166], 'patients': [16, 23], 'with': [17], 'castration-resistant': [18], 'prostate': [19], 'cancer': [20], '(CRPC).': [21], 'However,': [22], 'receiving': [24], 'ARSIs': [25], 'ultimately': [26], 'develop': [27], 'resistance': [28, 132, 142, 158], 'through': [29], 'various': [30, 122], 'complex': [31], 'mechanisms,': [32], 'including': [33, 74, 125], 'AR': [34, 42, 49, 55, 113, 154], 'mutations,': [35, 139], 'constitutively': [36], 'active': [37], 'AR-splice': [38], 'variants': [39], '(AR-Vs),': [40], 'overexpression.': [43], 'Here,': [44], 'we': [45], 'characterized': [46], 'a': [47, 162, 172], 'novel': [48], 'pure': [50], 'antagonist,': [51], 'TAS3681,': [52], 'which': [53, 130, 140, 156], 'inhibits': [54], 'transcriptional': [56, 119], 'activity': [57, 120], 'downregulates': [59], 'AR-full': [60], 'length': [61], '(AR-FL)': [62], 'AR-Vs.': [64], 'TAS3681': [65, 106, 116, 149, 169], 'reduced': [66], 'protein': [68], 'levels': [69], 'AR-FL': [71], 'AR-Vs': [73], 'AR-V7': [75], 'in': [76, 83, 86, 92], 'enzalutamide-resistant': [77], 'cells': [78], '(SAS': [79], 'MDV': [80], 'No.': [81], '3-14),': [82], 'vitro': [84], 'vivo,': [87], 'showing': [88], 'strong': [89], 'antitumor': [90], 'efficacy': [91], 'an': [93], 'AR-V7-positive': [94], 'xenograft': [95], 'model.': [96], 'In': [97], 'AR-overexpressing': [98], 'VCaP': [99], '(prostate': [100], 'cancer)': [101], 'cells,': [102], 'conversely': [103], 'to': [104, 133, 143, 159], 'effectively': [107], 'suppressed': [108], 'cell': [109], 'proliferation': [110], 'downregulated': [112], 'expression.': [114], 'Importantly,': [115], 'blocked': [117], 'mutant': [123], 'ARs,': [124], 'mutations': [126], 'F877L/T878A': [127], 'H875Y/T878A,': [129], 'confer': [131, 141], 'V716M': [136], 'H875Y': [138], 'darolutamide.': [144], 'Our': [145], 'results': [146], 'demonstrate': [147], 'that': [148], 'suppresses': [150], 'reactivation': [152], 'signaling,': [155], 'causes': [157], 'ARSIs,': [160], 'via': [161], 'newly': [163], 'identified': [164], 'mechanism': [165], 'action.': [167], 'Therefore,': [168], 'could': [170], 'be': [171], 'new': [173], 'therapeutic': [174], 'option': [175], 'for': [176], 'CRPC': [177], 'treatment.': [178]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4394724610', 'counts_by_year': [{'year': 2024, 'cited_by_count': 4}], 'updated_date': '2024-12-16T01:52:53.837771', 'created_date': '2024-04-12'}